Medicared For All Logo

Michael Moffett MD in Clovis, California

Home California Clovis

Michael Moffett MD has Hematology/oncology as his primary medical specialty. Their primary office is: 729 N Medical Ctr Dr W in Clovis, California.

They're a part of the: Community Health Partners medical group which has around 405 members. You can call their office at 559-299-6600 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Albany Medical College Of Union University and graduated in 1986 (around 38 years of experience). They are listed as doing telehealth appointments.


Michael J Moffett MD Office Phone and Directions

Michael Moffett MD
Community Health Partners
729 N Medical Ctr Dr W
Clovis, California 93611
559-299-6600


Patient Ratings
Please rate your experience with Michael Moffett MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 559-299-6600


Enter a starting address:


Healthcare Info for Michael Moffett MD

Additional Medical Specialties Include:
INTERNAL MEDICINE, MEDICAL ONCOLOGY

Medical School: Albany Medical College Of Union University
Graduation Year: 1986
The Primary Medical Specialty for Michael Moffett MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 0648176727
NPI #: 1407803083
NPI Created On: 05/28/2006
NPI Last Updated Listed as: 07/31/2019
Primary Taxonomy Code: 207RH0003X
License Number:
G80577
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  2. New patient office or other outpatient visit, typically 30 minutes
  3. New patient office or other outpatient visit, typically 45 minutes
  4. New patient office or other outpatient visit, typically 60 minutes
  5. Established patient office or other outpatient visit, typically 10 minutes
  6. Established patient office or other outpatient visit, typically 15 minutes
  7. Established patient office or other outpatient, visit typically 25 minutes
  8. Established patient office or other outpatient, visit typically 40 minutes
  9. Subsequent hospital inpatient care, typically 15 minutes per day
  10. Subsequent hospital inpatient care, typically 25 minutes per day
  11. Subsequent hospital inpatient care, typically 35 minutes per day
  12. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
  13. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
  14. Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783519425

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783519433

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $20

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783519499

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843384559

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology

Name of Drug #1: INQOVI

Open Associated Drug #1: 64842-0727-9


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2781886;EPRINTS;10191777

Record ID:: 845876733

Being Disputed:: No

Product Related: Yes


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 836294331

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: Enhertu

Open Associated Drug #1: 65597-406-01


Payments Total: $7

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 851660263

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ORAL ONCOLOGIC

Name of Drug #1: FARYDAK

Open Associated Drug #1: 0078-0650-06

Drug or Biological: Drug

Product Category #2: ORAL ONCOLOGIC

Name Of Drug #2:: COPIKTRA

Associated Drug #2: 73116-115-01


Payments Total: $123

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 851660267

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ORAL ONCOLOGIC

Name of Drug #1: FARYDAK

Open Associated Drug #1: 0078-0650-06

Drug or Biological: Drug

Product Category #2: ORAL ONCOLOGIC

Name Of Drug #2:: COPIKTRA

Associated Drug #2: 73116-115-01


Payments Total: $116

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 851660271

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ORAL ONCOLOGIC

Name of Drug #1: FARYDAK

Open Associated Drug #1: 0078-0650-06

Drug or Biological: Drug

Product Category #2: ORAL ONCOLOGIC

Name Of Drug #2:: COPIKTRA

Associated Drug #2: 73116-115-01


Payments Total: $127

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 851660275

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ORAL ONCOLOGIC

Name of Drug #1: FARYDAK

Open Associated Drug #1: 0078-0650-06

Drug or Biological: Drug

Product Category #2: ORAL ONCOLOGIC

Name Of Drug #2:: COPIKTRA

Associated Drug #2: 73116-115-01


Hematology/oncology Professionals in Clovis

785 N Medical Ctr Dr W
Clovis, CA
Community Health Partners

785 N Medical Ctr Dr W
Clovis, CA
Community Health Partners

785 N Medical Ctr Dr W
Clovis, CA
Community Health Partners

785 N Medical Ctr Dr W
Clovis, CA
Community Health Partners

785 N Medical Ctr Dr W
Clovis, CA
Community Health Partners

Providers in Community Health Partners

1.Shahrin Abdalian

2755 Herndon Ave
Clovis Ca 93611-6800
Community Health Partners
Nurse Practitioner

2.Shahrin Abdalian

2823 Fresno St
Fresno Ca 93721-1324
Community Health Partners
Nurse Practitioner

3.Kerolos Abdelmalek

2755 Herndon Ave
Clovis Ca 93611-6800
Community Health Partners
Internal Medicine

4.Kerolos Abdelmalek

2823 Fresno St
Fresno Ca 93721-1324
Community Health Partners
Internal Medicine

5.Haifaa Abdulhaq

785 N Medical Ctr Dr W
Clovis Ca 93611-6878
Community Health Partners
Hematology/oncology

6.Majdi Abdulmaula

2823 Fresno St
Fresno Ca 93721-1324
Community Health Partners
Internal Medicine

View all 405 members of Community Health Partners medical group